Hepatic Steatosis in Primary Aldosteronism, Cushing’s Syndrome, and Mild Autonomous cortisol secretion: Metabolic and Hormonal Associations
Year: 2026
Type: article
Study design: Observational Study
Abstract: CONTEXT: Metabolic dysfunction-associated steatotic liver disease (MASLD) is closely linked to obesity, diabetes mellitus (DM), and dyslipidemia. Patients with primary aldosteronism (PA), Cushing's syndrome (CS) and mild autonomous cortisol secretion (MACS) exhibit metabolic abnormalities, but the relative contributions of hormonal and metabolic factors to hepatic steatosis remain unclear. OBJECTIVE: To evaluate MASLD prevalence and determinants in PA, CS, and MACS. DESIGN: Single-center retrospective cross-sectional study. METHODS: 243 treatment-naive patients underwent unenhanced abdominal computed tomography: 102 isolated PA, 60 CS, 47 MACS, and 34 PA with cortisol co-secretion. Hepatic steatosis was assessed using liver-to-spleen (L/S) attenuation ratio. Hepatic steatosis index (HSI), and triglyceride-glucose (TyG) index were calculated. RESULTS: MASLD prevalence was 28.4% in isolated PA, 26.6% in CS, 31.9% in MACS and 26.4% in PA with cortisol co-secretion. Liver attenuation and L/S ratio were similar across groups but correlated with visceral adiposity, glucose, HbA1c, triglycerides, HSI, and TyG index (all r>0.5, p<0.05). DM was independently associated with lower liver attenuation after adjustment for age, sex, and BMI (β = -11.10 HU, 95% CI: -16.40 to -5.79). Serum cortisol, cortisol after the 1-mg DST, aldosterone, and renin were not independently associated with hepatic steatosis, whereas UFC was independently associated with the L/S attenuation ratio in the hypercortisolism subgroup. CONCLUSIONS: Hepatic steatosis was similarly prevalent across PA, CS, and MACS, and was associated with metabolic factors, particularly DM, BMI, visceral adiposity, and hypertriglyceridemia. These findings support consideration of hepatic steatosis assessment in patients with functional adrenal disorders and metabolic risk factors.
Source: Endocrine Connections
DOI: 10.1530/ec-26-0493
Authors: Tugce Apaydin, Júnia R. O. L. Schweizer, Isabel Stüfchen, Elisabeth Nowak, Matthias Oettle, Moritz Schrenk, Markus Kroiss, Martin Reincke, Nicole Reisch, Jens Ricke, Max Seidensticker, Matthias P. Fabritius, Lalith Kumar, Moritz Wildgruber, Christine Schmid-Tannwald, Friederike Völter, Nabeel Mansour
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,146
Funder: Deutsche Forschungsgemeinschaft
OpenAlex ID: W7225993348
